Evelyn Hsieh, MD, PhD, and Eric L. Matteson, MD, MACR, of the ACR’s Global Engagement Special Committee preview the topics and experts that will be a part of the all-day summit on Nov. 3. The summit is included with the All-Access Pass.
ACR Convergence 2021 will have a slightly updated schedule to maximize the educational and networking opportunities.
Dr. Karp shares highlights for the meeting, which starts Nov. 1 with early access to the virtual platform and continuing through the ACR Review Course on Nov. 10.
Of all the questions raised by the COVID-19 pandemic, its effect on children has been one of the most perplexing.
Only 1 in 20 individuals with the disease report being referred for a Sjögren’s workup by their eye care provider, according to a patient survey supported by the Sjögren’s Foundation.
There is a clear need for more, and more effective, tests for antiphospholipid syndrome. The current battery of lupus anticoagulant, anti-cardiolipin antibody, and anti-β2-glycoprotein-I is far from ideal.
The skin can offer clues to help make the correct diagnosis for many pediatric rheumatology diseases, and a session at ACR Convergence 2020 shared some of the most important things to look for when making a diagnosis.
Traditionally used in research, patient-reported outcomes have expanded into healthcare quality evaluations as well as clinical practice since being introduced to rheumatology in the 1980s.
COPA syndrome is a dysfunction of lung epithelial cells producing surfactant that is virtually indistinguishable from a variety of rheumatic diseases on initial examination.
A better understanding of COVID-19’s pathogenesis, manifestations, natural history, and immunopathology will bring more safe and effective therapies.